A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.

Sponsor
Pfizer


Hotbed News
First-Ever CRISPR Trial Points to Looming Problems Wednesday, June 29, 2016
Life Or Death: Why Chinese Patients Mix Drug Cocktails At Home Wednesday, June 29, 2016
Researchers Blame Childhood Obesity, Endocrine Disruptors On Early Puberty, University of Hong Kong Study Friday, June 24, 2016
Spring Rain Mobile Healthcare App Raises $183 Million, Plans China IPO Friday, June 24, 2016
Pfizer (PFE) Expands and Invests $350 Million in China Biotech Hub, First in Asia Wednesday, June 29, 2016
3 Tips that Could Help Biotech Investors Make Big Bucks Wednesday, June 08, 2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer Thursday, June 16, 2016
Children Less Likely To Trust Ugly People, Zhejiang Sci-Tech University Study Thursday, June 16, 2016
Gan & Lee Plans $226 Million China IPO Friday, June 17, 2016
Frontier Biotechnologies Reports Primary Endpoint Met In Phase 2 Trial Of AB001 In Chronic Low Back Pain Wednesday, June 22, 2016
12345678910